Showing results (1381-1390 of 2,043) with videos related to
Sort By:
Pageof 205
International Immunopharmacology|November 1, 2024
CD83 mediates the inhibitory effect of the S1PR1 agonist CYM5442 on LPS-induced M1 polarization of macrophages through the ERK-STAT-1 signaling pathwayMeiHua Luo, Wei Zhang, Juan Yang, et al.Food & Function|May 31, 2022
Baicalin alleviates endometrial inflammatory injury through regulation of tight junction proteinsDiqi Yang, Ruiling Yin, Qianghui Lei, et al.Journal of Neurosurgery|February 4, 2022
Association of occlusion time with successful endovascular recanalization in patients with symptomatic chronic intracranial total occlusionBo Yang, Kaijiang Kang, Feng Gao, et al.Stroke and Vascular Neurology|August 28, 2023
Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosisYing Yu, Yake Lou, Yuesong Pan, et al.Medical Ultrasonography|November 26, 2019
Speckle tracking echocardiography in early detection of myocardial injury in a rat model with stress cardiomyopathyHongju Zhang, Yan Sun, Xiaoran Liu, et al.Molecular Immunology|January 21, 2019
Ebi3 promotes T- and B-cell division and differentiation via STAT3Ning Ma, Ying Fang, Ruonan Xu, et al.Frontiers in Nutrition|September 15, 2022
The independent and combined effects of single-child status and ideal lifestyle on clustered cardio-metabolic risk factors among Chinese children and adolescentsJiajia Dang, Ning Ma, Yunfei Liu, et al.Nutrients|August 12, 2022
The Combined Effect of Birth Weight and Lifestyle on Clustered Cardio-Metabolic Risk Factors in Children and Adolescents: A National School-Based Cross-Sectional SurveyDi Shi, Jiajia Dang, Ning Ma, et al.Journal of Neurosurgery|August 13, 2022
Impact of cerebral small vessel disease on symptomatic in-stent restenosis in intracranial atherosclerosisWeilun Fu, Long Yan, Zhikai Hou, et al.Journal of Cancer|August 2, 2021
Continuing Cetuximab <i>vs</i> Bevacizumab plus chemotherapy after first progression in wild-type <i>KRAS</i>, <i>NRAS</i> and <i>BRAF V600E</i> metastatic colorectal cancer: a randomized phase II trialDanyang Li, Feng Wang, Shuning Xu, et al.Pageof 205